Hoth Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing therapies for unmet medical needs. Its primary pipeline includes HT-001 (topical treatment for cancer drug side effects), HT-KIT (treatment for mast-cell cancers and anaphylaxis), and HT-ALZ (Alzheimer's and neuroinflammatory diseases). Additional assets include BioLexa (atopic dermatitis), HT-004 (asthma/allergies), and HT-VA (obesity). The company relies on licensed intellectual property from universities and government agencies, with no internal manufacturing capability.
Q2 FY2026 — expected 2026-09-11
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-27 | 2025-12-31 | 0001213900-26-035625 | EDGAR | 68K words |
| 2025-03-28 | 2024-12-31 | 0001013762-25-004108 | EDGAR | 77K words |
| 2024-03-28 | 2023-12-31 | 0001213900-24-027213 | EDGAR | 62K words |
| 2023-03-31 | 2022-12-31 | 0001213900-23-025455 | EDGAR | — |
| 2022-03-30 | 2021-12-31 | 0001213900-22-015909 | EDGAR | — |
| 2021-03-16 | 2020-12-31 | 0001213900-21-015764 | EDGAR | — |
| 2020-03-02 | 2019-12-31 | 0001213900-20-005186 | EDGAR | — |
| 2019-04-01 | 2018-12-31 | 0001213900-19-005307 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-14 | 2026-06-30 | 0001213900-26-090048 | EDGAR | 28K words |
| 2025-11-12 | 2025-09-30 | 0001213900-25-109220 | EDGAR | 27K words |
| 2025-08-12 | 2025-06-30 | 0001213900-25-074968 | EDGAR | 23K words |
| 2025-05-12 | 2025-03-31 | 0001213900-25-042043 | EDGAR | 19K words |
| 2024-11-12 | 2024-09-30 | 0001213900-24-096778 | EDGAR | 23K words |
| 2024-08-09 | 2024-06-30 | 0001213900-24-067131 | EDGAR | 22K words |
| 2024-05-14 | 2024-03-31 | 0001213900-24-042906 | EDGAR | 17K words |
| 2023-11-13 | 2023-09-30 | 0001213900-23-086133 | EDGAR | 17K words |
| 2023-08-11 | 2023-06-30 | 0001213900-23-066246 | EDGAR | 15K words |
| 2023-05-15 | 2023-03-31 | 0001213900-23-039789 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001213900-22-071279 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001213900-22-047409 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-25 | 0001213900-26-103530 | EDGAR | 1K words |
| 2026-09-22 | 0001213900-26-102217 | EDGAR | 1K words |
| 2026-08-11 | 0001213900-26-087771 | EDGAR | 1K words |
| 2026-07-31 | 0001213900-26-083962 | EDGAR | 1K words |
| 2026-07-21 | 0001213900-26-079817 | EDGAR | 3K words |
| 2026-04-02 | 0001213900-26-039363 | EDGAR | 23K words |
| 2026-01-16 | 0001213900-26-004899 | EDGAR | 1K words |
| 2025-10-17 | 0001213900-25-099969 | EDGAR | 2K words |
| 2025-09-12 | 0001213900-25-087054 | EDGAR | 1K words |
| 2025-08-22 | 0001213900-25-079915 | EDGAR | 11K words |
156 total filings indexed. 126 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001711786 |
| Ticker | HOTH |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | NV |
| Website | https://www.hoththerapeutics.com |
| Listed | 2019-02-15 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HOTH (~200 tokens, structured JSON with cryptographic provenance)